Marianna Criscuolo

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

Nicola Normanno, Anna Maria Rachiglio, Matilde Lambiase et al. · Annals of Oncology · 2015 · 145 citations · Full text

Capri Goim Trial, Medicine, Pathology +8

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Maria Teresa Voso, Susanna Fenu, Roberto Latagliata et al. · Journal of Clinical Oncology · 2013 · 136 citations · Full text

Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas

Stefan Hohaus, Manuela Giachelia, Giuseppina Massini et al. · Annals of Oncology · 2009 · 132 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +6

Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the <scp>I</scp>talian network on secondary leukemias

Luana Fianchi, Livio Pagano, Alfonso Piciocchi et al. · American Journal of Hematology · 2015 · 121 citations · Full text

Hematological Malignancy, Shorter Latency, Therapy‐related Myeloid Neoplasms +13

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

Fabio Efficace, Gianluca Gaïdano, Massimo Breccia et al. · British Journal of Haematology · 2014 · 74 citations · Full text

Quality Of Life, Fatigue Severity, Life Assessment +16